Antigenic Determinants of SARS-CoV-2-Specific CD4


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 24 02 2022
accepted: 09 05 2022
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 20 7 2022
Statut: epublish

Résumé

We generated CD4

Identifiants

pubmed: 35844575
doi: 10.3389/fimmu.2022.883159
pmc: PMC9279651
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

883159

Informations de copyright

Copyright © 2022 Gazzinelli-Guimaraes, Sanku, Sette, Weiskopf, Schaughency, Lack and Nutman.

Déclaration de conflit d'intérêts

AS is a consultant for Gritstone Bio, Flow Pharma, Arcturus Therapeutics, ImmunoScape, CellCarta, Oxford Immunotec, and Avalia Immunotherapies. JL has filed for patent protection for various aspects of T cell epitope and vaccine design work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Immunol. 2020 Oct 08;11:589380
pubmed: 33178221
Cell. 2020 Nov 25;183(5):1354-1366.e13
pubmed: 33065030
Methods Mol Med. 2008;138:31-41
pubmed: 18612602
Exp Mol Med. 2021 May;53(5):750-760
pubmed: 33953323
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
Nat Rev Microbiol. 2018 Jul;16(7):423-439
pubmed: 29769653
Cell Rep. 2020 Oct 6;33(1):108234
pubmed: 32979938
J Biol Chem. 1992 Apr 15;267(11):7806-13
pubmed: 1373138
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15623-8
pubmed: 9861020
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Nat Med. 2020 Jun;26(6):842-844
pubmed: 32398875
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Nat Immunol. 2021 Jan;22(1):74-85
pubmed: 32999467
Signal Transduct Target Ther. 2020 Dec 28;5(1):299
pubmed: 33372174
Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Cell. 2011 Jan 21;144(2):296-309
pubmed: 21241896
J Biol Chem. 2009 Jun 12;284(24):16202-16209
pubmed: 19380580
Cell Mol Immunol. 2021 Mar;18(3):613-620
pubmed: 33110251
J Immunol. 2008 Oct 15;181(8):5490-500
pubmed: 18832706
Cell Stress. 2020 Mar 02;4(4):66-75
pubmed: 32292881
Front Immunol. 2020 Sep 30;11:580641
pubmed: 33101306
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
Front Immunol. 2018 Sep 11;9:2061
pubmed: 30254639
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Sci Immunol. 2020 Jul 15;5(49):
pubmed: 32669287
Nat Biotechnol. 2018 Jan;36(1):89-94
pubmed: 29227470
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
J Clin Invest. 1984 Jun;73(6):1754-62
pubmed: 6233302
Science. 1994 Jun 24;264(5167):1918-21
pubmed: 8009221
Annu Rev Microbiol. 2019 Sep 8;73:529-557
pubmed: 31226023
Cell Mol Immunol. 2020 May;17(5):541-543
pubmed: 32203186
Nat Immunol. 2020 Nov;21(11):1336-1345
pubmed: 32887977
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
Eur J Immunol. 2020 Dec;50(12):1998-2012
pubmed: 33073359
Immunity. 2020 Jun 16;52(6):971-977.e3
pubmed: 32413330
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059

Auteurs

Pedro H Gazzinelli-Guimaraes (PH)

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States.

Gayatri Sanku (G)

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States.

Alessandro Sette (A)

Center for Infectious Disease, La Jolla Institute for Immunology, La Jolla, CA, United States.

Daniela Weiskopf (D)

Center for Infectious Disease, La Jolla Institute for Immunology, La Jolla, CA, United States.

Paul Schaughency (P)

Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, MD, United States.

Justin Lack (J)

Frederick National Laboratory for Cancer Research, National Institutes of Health, Frederick, MD, United States.

Thomas B Nutman (TB)

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH